{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,25]],"date-time":"2026-01-25T05:11:39Z","timestamp":1769317899165,"version":"3.49.0"},"reference-count":95,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2008,12,1]],"date-time":"2008-12-01T00:00:00Z","timestamp":1228089600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Best Practice &amp; Research Clinical Gastroenterology"],"published-print":{"date-parts":[[2008,12]]},"DOI":"10.1016\/j.bpg.2008.11.008","type":"journal-article","created":{"date-parts":[[2009,2,1]],"date-time":"2009-02-01T09:19:57Z","timestamp":1233479997000},"page":"1009-1029","source":"Crossref","is-referenced-by-count":15,"title":["Prevention of viral hepatitis (B and C) reassessed"],"prefix":"10.1016","volume":"22","author":[{"given":"Koen","family":"Van Herck","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Vorsters","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Van Damme","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"No. RR-16","key":"10.1016\/j.bpg.2008.11.008_bib1","first-page":"1","article-title":"A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States: recommendations of the Advisory Committee on Immunization Practices (ACIP). Part II: immunization of adults","volume":"55","author":"Centers for Disease Control and Prevention","year":"2006","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.bpg.2008.11.008_bib2","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1136\/oem.2006.032334","article-title":"Hepatitis B virus, hepatitis C virus and other blood-borne infections in health-care workers: guidelines for prevention and management in industrialised countries","volume":"65","author":"FitzSimons","year":"2008","journal-title":"Occup Environ Med"},{"key":"10.1016\/j.bpg.2008.11.008_bib3","series-title":"Viral Hepatitis","first-page":"1","article-title":"Clinical features of hepatitis","author":"Sherlock","year":"1993"},{"key":"10.1016\/j.bpg.2008.11.008_bib4","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1001\/jama.295.1.65","article-title":"Risk of HCC across a biological gradient of serum HBV-DNA levels","volume":"295","author":"Chen","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/j.bpg.2008.11.008_bib5","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1046\/j.1365-2893.2003.00487.x","article-title":"Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures","volume":"11","author":"Lavanchy","year":"2004","journal-title":"J Viral Hepat"},{"issue":"Suppl. 1","key":"10.1016\/j.bpg.2008.11.008_bib6","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/S1386-6532(05)00384-7","article-title":"Worldwide epidemiology of HBV infection, disease burden, and vaccine prevention","volume":"34","author":"Lavanchy","year":"2005","journal-title":"J Clin Virol"},{"key":"10.1016\/j.bpg.2008.11.008_bib7","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1128\/CMR.12.2.351","article-title":"Update on diagnosis, management and prevention of hepatitis B virus infection","volume":"12","author":"Mahoney","year":"1999","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.bpg.2008.11.008_bib8","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1093\/ije\/dyi206","article-title":"A mathematical model to estimate global hepatitis B disease burden and vaccination impact","volume":"34","author":"Goldstein","year":"2005","journal-title":"Int J Epidemiol"},{"key":"10.1016\/j.bpg.2008.11.008_bib9","series-title":"Informal Consultation on Quadrivalent Diphtheria\u2013Tetanus\u2013Pertussis\u2013Hepatitis B vaccine","author":"World Health Organization","year":"1992"},{"key":"10.1016\/j.bpg.2008.11.008_bib10","first-page":"255","article-title":"Hepatitis B vaccines (WHO position paper)","volume":"79","author":"World Health Organization","year":"2004","journal-title":"Wkly Epidemiol Rec"},{"key":"10.1016\/j.bpg.2008.11.008_bib11","series-title":"Viral Hepatitis and Liver Disease","first-page":"559","article-title":"Epidemiological trends of viral hepatitis in Asia","author":"Tandon","year":"1997"},{"key":"10.1016\/j.bpg.2008.11.008_bib12","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1002\/hep.1840010502","article-title":"A controlled clinical trial of the efficacy of the hepatitis B vaccine (Hepatavax B): a final report","volume":"5","author":"Szmuness","year":"1981","journal-title":"Hepatology"},{"key":"10.1016\/j.bpg.2008.11.008_bib13","first-page":"353","article-title":"Update on hepatitis B prevention","volume":"36","author":"Centers for Disease Control and Prevention","year":"1987","journal-title":"Morb Mortal Wkly Rep"},{"key":"10.1016\/j.bpg.2008.11.008_bib14","doi-asserted-by":"crossref","first-page":"2781","DOI":"10.1016\/j.vaccine.2006.01.007","article-title":"Comparative immunogenicity of a PreS\/S hepatitis B vaccine in non- and low responders to conventional vaccine","volume":"24","author":"Rendi-Wagner","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.bpg.2008.11.008_bib15","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.tmaid.2006.04.004","article-title":"A review of the long-term protection after hepatitis A and B vaccination","volume":"5","author":"Van Damme","year":"2007","journal-title":"Travel Med Infect Dis"},{"key":"10.1016\/j.bpg.2008.11.008_bib16","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1136\/sti.2006.022111","article-title":"Schedules for hepatitis B vaccination of risk groups: balancing immunogenicity and compliance","volume":"83","author":"Van Herck","year":"2007","journal-title":"Sex Transm Infect"},{"key":"10.1016\/j.bpg.2008.11.008_bib17","first-page":"13","article-title":"Review of 12 million doses shows hepatitis B vaccine safe","volume":"4","author":"Niu","year":"1996","journal-title":"Vaccine Wkly"},{"key":"10.1016\/j.bpg.2008.11.008_bib18","doi-asserted-by":"crossref","first-page":"S83","DOI":"10.1016\/S0168-8278(03)00153-3","article-title":"Safety of immunization and adverse events following vaccination against hepatitis B","volume":"39","author":"Duclos","year":"2003","journal-title":"J Hepatol"},{"key":"10.1016\/j.bpg.2008.11.008_bib19","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0264-410X(99)00179-6","article-title":"Over a decade of experience with the yeast recombinant hepatitis B vaccine","volume":"18","author":"Safary","year":"1999","journal-title":"Vaccine"},{"key":"10.1016\/j.bpg.2008.11.008_bib20","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1586\/14760584.3.2.119","article-title":"Recombivax-HB: perspectives past, present and future","volume":"3","author":"Venters","year":"2004","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.bpg.2008.11.008_bib21","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1097\/00000441-197509000-00025","article-title":"Purified and inactivated human hepatitis B vaccine: a progress report","volume":"270","author":"Hilleman","year":"1975","journal-title":"Am J Med Sci"},{"key":"10.1016\/j.bpg.2008.11.008_bib22","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.2165\/00003495-200363100-00006","article-title":"Recombinant hepatitis B vaccine (Engerix-B): a review of its immunogenicity and protective efficacy against hepatitis B","volume":"63","author":"Keating","year":"2003","journal-title":"Drugs"},{"key":"10.1016\/j.bpg.2008.11.008_bib23","first-page":"8168","article-title":"Hepatitis B vaccine in health-care personnel: safety, immunogenicity, and indicators of efficacy","volume":"82","author":"Dienstag","year":"1984","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.bpg.2008.11.008_bib24","first-page":"171","article-title":"The human immune response to hepatitis B surface antigen","volume":"12","author":"Alper","year":"1995","journal-title":"Exp Clin Immunogenet"},{"issue":"Suppl. 3A","key":"10.1016\/j.bpg.2008.11.008_bib25","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/0002-9343(89)90530-5","article-title":"Factors influencing the immune response to hepatitis B vaccine, booster dose guidelines and vaccine protocol recommendations","volume":"87","author":"Hollinger","year":"1989","journal-title":"Am J Med"},{"key":"10.1016\/j.bpg.2008.11.008_bib26","first-page":"282","article-title":"Hepatitis B immunization: vaccine types, efficacy, and indications for immunization","volume":"vol. 12","author":"Hadler","year":"1992"},{"key":"10.1016\/j.bpg.2008.11.008_bib27","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1016\/S0140-6736(05)67544-7","article-title":"Hepatitis B vaccination: to boost or not to boost?","volume":"366","author":"Kao","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.bpg.2008.11.008_bib28","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1016\/S0140-6736(05)67568-X","article-title":"Long-term immunogenicity of hepatitis B vaccination and policy for booster: an Italian multicentre study","volume":"366","author":"Zanetti","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.bpg.2008.11.008_bib29","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1016\/0264-410X(96)00062-X","article-title":"Vaccine induced immunologic memory for hepatitis B surface antigen: implications for policy on booster vaccination","volume":"14","author":"West","year":"1996","journal-title":"Vaccine"},{"key":"10.1016\/j.bpg.2008.11.008_bib30","first-page":"1","article-title":"Hepatitis B vaccine-do we need boosters?","volume":"10","author":"Banatvala","year":"2003","journal-title":"J Hepatol"},{"key":"10.1016\/j.bpg.2008.11.008_bib31","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/S0140-6736(99)07239-6","article-title":"Are booster immunisations needed for lifelong hepatitis B immunity?","volume":"355","author":"European Consensus Group on Hepatitis B immunity","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.bpg.2008.11.008_bib32","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1111\/j.1537-2995.2007.01482.x","article-title":"Reducing the risk of transfusion-transmissible viral infection through blood donor selection: the Australian experience 2000 through 2006","volume":"48","author":"Polizzotto","year":"2008","journal-title":"Transfusion"},{"key":"10.1016\/j.bpg.2008.11.008_bib33","author":"World Health Organization"},{"key":"10.1016\/j.bpg.2008.11.008_bib34","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1002\/jmv.1890440206","article-title":"Review: protective efficacy of hepatitis B vaccines in neonates","volume":"44","author":"Andr\u00e9","year":"1994","journal-title":"J Med Virol"},{"key":"10.1016\/j.bpg.2008.11.008_bib35","series-title":"Expanded Programme on Immunization. Introduction of Hepatitis B Vaccination into Childhood Immunization Services: Management Guidelines, Including Information for Health Workers and Parents (WHO\/V&B\/01.31)","author":"World Health Organization","year":"2001"},{"key":"10.1016\/j.bpg.2008.11.008_bib36","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1097\/INF.0b013e318173966f","article-title":"Benefits of early hepatitis B immunization programs for newborns and infants","volume":"27","author":"Van Herck","year":"2008","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.bpg.2008.11.008_bib37","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/S0168-8278(05)80404-0","article-title":"Twelve-year follow-up study of hepatitis B immunisation of Senegalese infants","volume":"21","author":"Coursaget","year":"1994","journal-title":"J Hepatol"},{"key":"10.1016\/j.bpg.2008.11.008_bib38","doi-asserted-by":"crossref","first-page":"367","DOI":"10.7326\/0003-4819-97-3-367","article-title":"Accidental hepatitis-B-surface-antigen-positive inoculations: use of e antigen to estimate infectivity","volume":"97","author":"Werner","year":"1982","journal-title":"Ann Intern Med"},{"issue":"RR-11","key":"10.1016\/j.bpg.2008.11.008_bib39","first-page":"1","article-title":"Updated U.S. Public Health Service guidelines for the management of occupational exposures to HBV, HCV, and HIV and recommendations for postexposure prophylaxis","volume":"50","author":"Centers for Disease Control and Prevention","year":"2001","journal-title":"MMWR Recomm Rep"},{"key":"10.1016\/j.bpg.2008.11.008_bib40","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.ajic.2007.03.002","article-title":"Variation in interpretation and counselling of blood exposure incidents by different medical practitioners","volume":"36","author":"Van Wijk","year":"2008","journal-title":"Am J Infect Control"},{"key":"10.1016\/j.bpg.2008.11.008_bib41","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1086\/518730","article-title":"Hepatitis B vaccination coverage levels among health-care workers in the United States, 2002-2003","volume":"28","author":"Simard","year":"2007","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1016\/j.bpg.2008.11.008_bib42","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/S1386-6532(03)00087-8","article-title":"Hepatitis B virus (HBV) and hepatitis C virus (HCV) infections in health care workers (HCWs): guidelines for prevention of transmission of HBV and HCV from HCW to patients","volume":"27","author":"Gunson","year":"2003","journal-title":"J Clin Virol"},{"key":"10.1016\/j.bpg.2008.11.008_bib43","first-page":"1","article-title":"Hepatitis B vaccination: how to reach risk groups","volume":"10","author":"Viral Hepatitis Prevention Board","year":"2001","journal-title":"J Viral Hepat"},{"key":"10.1016\/j.bpg.2008.11.008_bib44","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/S1473-3099(07)70237-2","article-title":"Vaccine immunogenicity in injecting drug users: a systematic review","volume":"7","author":"Baral","year":"2007","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.bpg.2008.11.008_bib45","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1111\/j.1360-0443.2007.01936.x","article-title":"The importance of social networks in their association to drug equipment sharing among injection drug users: a review","volume":"102","author":"De","year":"2007","journal-title":"Addiction"},{"key":"10.1016\/j.bpg.2008.11.008_bib46","series-title":"Vaccines","first-page":"205","article-title":"Hepatitis B vaccines","author":"Mast","year":"2008"},{"key":"10.1016\/j.bpg.2008.11.008_bib47","series-title":"Manual for the Surveillance of Vaccine-preventable Diseases","article-title":"Chapter 4: hepatitis B","author":"Finelli","year":"2008"},{"key":"10.1016\/j.bpg.2008.11.008_bib48","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1126\/science.2523562","article-title":"Isolation of a cDNA clone derived from a blood-born non-A, non-B viral hepatitis genome","volume":"244","author":"Choo","year":"1989","journal-title":"Science"},{"key":"10.1016\/j.bpg.2008.11.008_bib49","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1056\/NEJM199606273342601","article-title":"The risk of transfusion-transmitted viral infections. The Retrovirus Epidemiology Donor Study","volume":"334","author":"Schreiber","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bpg.2008.11.008_bib50","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/S1473-3099(05)70216-4","article-title":"Global epidemiology of hepatitis C virus infection","volume":"5","author":"Shepard","year":"2005","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.bpg.2008.11.008_bib51","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.jhep.2006.07.003","article-title":"Transmission of hepatitis C virus by blood transfusions and other medical procedures: a global review","volume":"45","author":"Prati","year":"2006","journal-title":"J Hepatol"},{"key":"10.1016\/j.bpg.2008.11.008_bib52","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.jhep.2007.07.033","article-title":"The changing epidemiology of hepatitis C virus infection in Europe","volume":"48","author":"Esteban","year":"2008","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.bpg.2008.11.008_bib53","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1055\/s-2000-9506","article-title":"Epidemiology of hepatitis C: geographic differences and temporal trends","volume":"20","author":"Wasley","year":"2000","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.bpg.2008.11.008_bib54","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/0196-6553(95)90056-X","article-title":"Risk of hepatitis C seroconversion after occupational exposures in health care workers. Italian Study Group on occupational risk of HIV and other bloodborne infections","volume":"23","author":"Puro","year":"1995","journal-title":"Am J Infect Control"},{"key":"10.1016\/j.bpg.2008.11.008_bib55","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1016\/S0140-6736(95)90565-0","article-title":"Shaving as potential source of hepatitis C virus infection","volume":"345","author":"Tumminelli","year":"1995","journal-title":"Lancet"},{"key":"10.1016\/j.bpg.2008.11.008_bib56","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/S0140-6736(96)91172-1","article-title":"Hepatitis C transmission by cosmetic tattooing in women","volume":"347","author":"Sun","year":"1996","journal-title":"Lancet"},{"issue":"5 Suppl 1","key":"10.1016\/j.bpg.2008.11.008_bib57","doi-asserted-by":"crossref","first-page":"S99","DOI":"10.1002\/hep.1840360713","article-title":"Sexual activity as a risk factor for hepatitis C","volume":"36","author":"Terrault","year":"2002","journal-title":"Hepatology"},{"key":"10.1016\/j.bpg.2008.11.008_bib58","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1086\/516792","article-title":"Sex, Drugs, and Hepatitis C Virus","volume":"195","author":"Hahn","year":"2007","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.bpg.2008.11.008_bib59","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1046\/j.1365-2893.2002.00329.x","article-title":"Hepatitis C: an epidemiological review","volume":"9","author":"Memon","year":"2002","journal-title":"J Viral Hepat"},{"key":"10.1016\/j.bpg.2008.11.008_bib60","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1086\/522608","article-title":"Acute hepatitis C in a contemporary US cohort: modes of acquisition and factors influencing viral clearance","volume":"196","author":"Wang","year":"2007","journal-title":"J Infect Dis"},{"key":"10.1016\/j.bpg.2008.11.008_bib61","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1086\/428121","article-title":"Hepatitis C virus coinfection and HIV load, CD4+ cell percentage, clinical progression to AIDS or death among HIV-infected women: women and infants transmission study","volume":"40","author":"Herschow","year":"2005","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.bpg.2008.11.008_bib62","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1002\/(SICI)1096-9071(199802)54:2<107::AID-JMV7>3.3.CO;2-O","article-title":"Multicenter trial on mother-to-infant transmission of GBV-C virus. The Lombardy Study Group on Vertical\/Perinatal Hepatitis Viruses Transmission","volume":"54","author":"Zanetti","year":"1998","journal-title":"J Med Virol"},{"issue":"5 Suppl. 1","key":"10.1016\/j.bpg.2008.11.008_bib63","doi-asserted-by":"crossref","first-page":"S173","DOI":"10.1002\/hep.1840360722","article-title":"Children with hepatitis C","volume":"36","author":"Jonas","year":"2002","journal-title":"Hepatology"},{"key":"10.1016\/j.bpg.2008.11.008_bib64","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.jcv.2006.11.012","article-title":"Discordant outcome of perinatal transmission of hepatitis C in twin pregnancies","volume":"38","author":"Boxall","year":"2007","journal-title":"J Clin Virol"},{"key":"10.1016\/j.bpg.2008.11.008_bib65","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.jcv.2007.07.005","article-title":"Anti-HCV IgG avidity index in acute hepatitis C","volume":"40","author":"Coppola","year":"2007","journal-title":"J Clin Virol"},{"key":"10.1016\/j.bpg.2008.11.008_bib66","doi-asserted-by":"crossref","first-page":"4776","DOI":"10.1128\/JVI.68.8.4776-4784.1994","article-title":"Genetic drift in hypervariable region I of the viral genome in persistent hepatitis C virus infection","volume":"68","author":"Kato","year":"1994","journal-title":"J Virol"},{"key":"10.1016\/j.bpg.2008.11.008_bib67","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2807\/ese.13.21.18879-en","article-title":"Acute hepatitis C virus infection","volume":"13","author":"Irving","year":"2008","journal-title":"Euro Surveill"},{"key":"10.1016\/j.bpg.2008.11.008_bib68","doi-asserted-by":"crossref","first-page":"2436","DOI":"10.3748\/wjg.v13.i17.2436","article-title":"Epidemiology of hepatitis C virus infection","volume":"13","author":"Alter","year":"2007","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.bpg.2008.11.008_bib69","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1111\/j.1365-2893.2004.00492.x","article-title":"Prevention of hepatitis C virus infection","volume":"11","author":"Kew","year":"2004","journal-title":"J Viral Hepat"},{"key":"10.1016\/j.bpg.2008.11.008_bib70","first-page":"35","article-title":"Global surveillance and control of hepatitis C. Report of a WHO consultation organized in collaboration with the Viral Hepatitis Prevention Board","volume":"6","author":"Anonymous","year":"1999","journal-title":"J Viral Hepat"},{"key":"10.1016\/j.bpg.2008.11.008_bib71","doi-asserted-by":"crossref","first-page":"2401","DOI":"10.1073\/pnas.91.7.2401","article-title":"Hepatitis viruses: changing patterns of human disease","volume":"91","author":"Purcell","year":"1994","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.bpg.2008.11.008_bib72","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1016\/S0140-6736(99)06527-7","article-title":"The role of parenteral antischistosomal therapy in the spread of hepatitis C virus in Egypt","volume":"355","author":"Frank","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.bpg.2008.11.008_bib73","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1046\/j.1365-2893.2002.00339.x","article-title":"Seroprevalence of hepatitis C markers among intravenous drug users in western European countries: a systematic review","volume":"9","author":"Mathei","year":"2002","journal-title":"J Viral Hepat"},{"key":"10.1016\/j.bpg.2008.11.008_bib74","first-page":"1","article-title":"Recommendations for preventing transmission of infections among chronic hemodialysis patients","volume":"50","author":"Centers for Disease Control and Prevention","year":"2001","journal-title":"MMWR Recomm Rep"},{"key":"10.1016\/j.bpg.2008.11.008_bib75","first-page":"35","article-title":"Global surveillance and control of hepatitis C. Report of a WHO Consultation organized in collaboration with the Viral Hepatitis Prevention Board, Antwerp, Belgium","volume":"6","author":"World Health Organization","year":"1999","journal-title":"J Viral Hepat"},{"key":"10.1016\/j.bpg.2008.11.008_bib76","doi-asserted-by":"crossref","first-page":"761","DOI":"10.7326\/0003-4819-143-10-200511150-00027","article-title":"Patient-to-patient transmission of hepatitis C","volume":"143","author":"Jadoul","year":"2005","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.bpg.2008.11.008_bib77","doi-asserted-by":"crossref","first-page":"2082","DOI":"10.1053\/gast.2002.1232082","article-title":"NIH Consensus Development Conference Statement: management of hepatitis C 2002","volume":"123","author":"National Institutes of Health","year":"2002","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bpg.2008.11.008_bib78","series-title":"Fields Virology","article-title":"Flaviviridae: the viruses and their replication","author":"Lindenbach","year":"2007"},{"key":"10.1016\/j.bpg.2008.11.008_bib79","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1016\/0042-6822(91)90104-J","article-title":"Variable and hypervariable domains are found in the regions of HCV corresponding to the flavivirus envelope and NS1 proteins and the pestivirus envelope glycoproteins","volume":"180","author":"Weiner","year":"1991","journal-title":"Virology"},{"key":"10.1016\/j.bpg.2008.11.008_bib80","doi-asserted-by":"crossref","first-page":"3923","DOI":"10.1128\/JVI.67.7.3923-3930.1993","article-title":"Humoral immune response to hypervariable region 1 of the putative envelope glycoprotein (gp70) of hepatitis C virus","volume":"67","author":"Kato","year":"1993","journal-title":"J Virol"},{"key":"10.1016\/j.bpg.2008.11.008_bib81","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1126\/science.288.5464.339","article-title":"The outcome of acute hepatitis C predicted by the evolution of the viral quasispecies","volume":"288","author":"Farci","year":"2000","journal-title":"Science"},{"key":"10.1016\/j.bpg.2008.11.008_bib82","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1084\/jem.20050808","article-title":"Mutational escape from CD8 + T-cell immunity: HCV evolution, from chimpanzees to man","volume":"201","author":"Bowen","year":"2005","journal-title":"J Exp Med"},{"key":"10.1016\/j.bpg.2008.11.008_bib83","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1038\/nature04077","article-title":"Unravelling hepatitis C virus replication from genome to function","volume":"436","author":"Lindenbach","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.bpg.2008.11.008_bib84","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1038\/nm1268","article-title":"Production of infectious hepatitis C virus in tissue culture from a cloned viral genome","volume":"11","author":"Wakita","year":"2005","journal-title":"Nat Med"},{"key":"10.1016\/j.bpg.2008.11.008_bib85","doi-asserted-by":"crossref","first-page":"11082","DOI":"10.1128\/JVI.01307-06","article-title":"Persistent hepatitis C virus infection in vitro: co-evolution of virus and host","volume":"80","author":"Zhong","year":"2006","journal-title":"J Virol"},{"key":"10.1016\/j.bpg.2008.11.008_bib86","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1126\/science.285.5424.110","article-title":"Replication of subgenomic hepatitis C virus RNAs in a hepatoma cell line","volume":"285","author":"Lohmann","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.bpg.2008.11.008_bib87","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/j.mib.2006.06.012","article-title":"Hepatitis C virus molecular clones: from cDNA to infectious virus particles in cell culture","volume":"9","author":"Bartenschlager","year":"2006","journal-title":"Curr Opin Microbiol"},{"key":"10.1016\/j.bpg.2008.11.008_bib88","doi-asserted-by":"crossref","first-page":"2310","DOI":"10.1073\/pnas.0510727103","article-title":"Production of infectious genotype 1a hepatitis C virus (Hutchinson strain) in cultured human hepatoma cells","volume":"103","author":"Yi","year":"2006","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.bpg.2008.11.008_bib89","doi-asserted-by":"crossref","first-page":"7142","DOI":"10.1128\/JVI.75.15.7142-7148.2001","article-title":"Intrahepatic genetic inoculation of hepatitis C virus RNA confers cross-protective immunity","volume":"75","author":"Weiner","year":"2001","journal-title":"J Virol"},{"key":"10.1016\/j.bpg.2008.11.008_bib90","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1016\/S0140-6736(02)08435-0","article-title":"Protection against persistence of hepatitis C","volume":"359","author":"Mehta","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.bpg.2008.11.008_bib91","series-title":"Vaccines","first-page":"1187","article-title":"Hepatitis C virus vaccines","author":"Reali","year":"2008"},{"key":"10.1016\/j.bpg.2008.11.008_bib92","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1111\/j.1365-2893.2004.00517.x","article-title":"Reconstructing and predicting the hepatitis C virus epidemic in Greece: increasing trends of cirrhosis and hepatocellular carcinoma despite the decline in incidence of HCV infection","volume":"11","author":"Sypsa","year":"2004","journal-title":"J Viral Hepat"},{"key":"10.1016\/j.bpg.2008.11.008_bib93","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1017\/S0950268802007902","article-title":"Monitoring hepatitis C virus infection among injecting drug users in the European Union: a review of the literature","volume":"129","author":"Roy","year":"2002","journal-title":"Epidemiol Infect"},{"key":"10.1016\/j.bpg.2008.11.008_bib94","series-title":"Recommendations for Postexposure Interventions to Prevent Infection with Hepatitis B Virus, Hepatitis C Virus, or Human Immunodeficiency Virus, and Tetanus in People Wounded During Bombings and Other Mass-Casualty Events \u2013- United States","author":"Centers for Disease Control and Prevention","year":"2008"},{"key":"10.1016\/j.bpg.2008.11.008_bib95","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1002\/hep.21197","article-title":"Duration of peginterferon therapy in acute hepatitis C: A randomized trial","volume":"43","author":"Kamal","year":"2006","journal-title":"Hepatology"}],"container-title":["Best Practice &amp; Research Clinical Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521691808000887?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521691808000887?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,3,9]],"date-time":"2024-03-09T21:56:12Z","timestamp":1710021372000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521691808000887"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,12]]},"references-count":95,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2008,12]]}},"alternative-id":["S1521691808000887"],"URL":"https:\/\/doi.org\/10.1016\/j.bpg.2008.11.008","relation":{},"ISSN":["1521-6918"],"issn-type":[{"value":"1521-6918","type":"print"}],"subject":[],"published":{"date-parts":[[2008,12]]}}}